查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595314

藥品合約包裝市場：按材料和應用分類 - 2025-2030 年全球預測

Pharmaceutical Contract Packaging Market by Material (Aluminum Foil, Glass, Paper & Paperboard), Application (Ampoules, Blister Packs, Bottles) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年藥品合約包裝市場規模為320.7億美元，預計2024年將達348.2億美元，複合年成長率為8.91%，2030年將達583億美元。

藥品合約包裝是指製藥公司將包裝服務外包給第三方提供者。這個行業至關重要，因為它使製藥公司能夠專注於其核心競爭力，例如藥物開發和行銷，同時利用合約包裝商的專業知識和能力來確保遵守行業標準和法規。藥物配方和包裝要求日益複雜、監管力度加大以及對更永續包裝解決方案的推動推動了合約包裝的需求。合約包裝的應用包括泡殼包裝、瓶子填充、標籤和二次包裝，最終用途範圍從契約製造組織 (CMO) 到製造非處方藥 (OTC) 和道德藥品的製藥公司。

主要市場統計
基準年[2023] 320.7億美元
預測年份 [2024] 348.2億美元
預測年份 [2030] 583億美元
複合年成長率（%） 8.91%

根據市場洞察，關鍵的成長要素包括對需要創新包裝解決方案的生技藥品和特種藥物的需求不斷成長、製藥行業外包趨勢的增加以及序列化和追蹤系統等包裝，其中包括工程技術的進步。市場相關人員的機會包括擴大服務組合，納入環保包裝解決方案，以及採用數位技術簡化包裝流程。此外，隨著製藥業的發展，向新興市場的地域擴張呈現出良好的前景。然而，挑戰包括嚴格的監管要求、成本壓力以及全球經濟不確定性導致的需求波動。

創新的希望在於開發智慧包裝解決方案，以提高患者用藥依從性、提高供應鏈透明度並促進身分驗證。生物分解性和可回收材料的持續研究可以提供競爭優勢。由於快速的技術進步和監管變化，市場競爭激烈且充滿活力。為了實現永續的業務成長，公司應投資最尖端科技並建立策略夥伴關係和聯盟，以增強服務交付。此外，積極主動的合規方法和對客戶獨特需求的高度關注對於在這個不斷發展的市場中應對挑戰和抓住機會至關重要。

市場動態：揭示快速發展的藥品合約包裝市場的關鍵市場洞察

供需的動態交互作用正在改變藥品合約包裝市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 製藥業對方便、防篡改包裝的需求不斷成長
    • 全球藥品製造及出口增加
    • 嚴格的藥品包裝政府標準
  • 市場限制因素
    • 先進和客製化的藥品合約包裝服務高成本
  • 市場機會
    • 藥品包裝解決方案的技術進步
    • 對藥物發現和開發的大量投資
  • 市場挑戰
    • 新開發藥品與包裝材料和仿冒品廣告之間的競爭

波特五力：駕馭藥品合約包裝市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥品合約包裝市場的外部影響

外部宏觀環境因素在塑造藥品合約包裝市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥品合約包裝市場的競爭狀況

對藥品合約包裝市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣藥品合約包裝市場供應商績效評估

FPNV定位矩陣是評估藥品合約包裝市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪藥品合約包裝市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對藥品合約包裝市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥業對方便且防篡改的包裝的需求日益成長。
      • 全球藥品生產和出口增加
      • 嚴格的藥品包裝政府標準
    • 抑制因素
      • 先進和客製化的藥品合約包裝服務高成本
    • 機會
      • 藥品包裝解決方案的技術進步
      • 對藥物發現和開發的大量投資
    • 任務
      • 新開發藥品違反包裝材料及廣告仿冒品
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品合約包裝市場：依材料分類

  • 鋁箔
  • 玻璃
  • 紙/紙板
  • 塑膠和聚合物

第7章 藥品合約包裝市場：依應用分類

  • 安瓿
  • 泡殼包裝
  • 瓶子
  • 管瓶

第8章美洲藥品合約包裝市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太藥品合約包裝市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲藥品合約包裝市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Almac Group
  • AmeriPac, Inc.
  • Aphena Pharma Solutions Inc.
  • Assemblies Unlimited Inc.
  • Baxter Pharmaceutical Solutions LLC
  • Catalent, Inc.
  • Central Pharma Contract Packing Limited
  • Daito Pharmaceutical Co., Ltd.
  • Daklapack Group
  • Finishing Services
  • Jam Jams Group
  • Jones Healthcare Group
  • MJS Packaging
  • Nelipak Corporation
  • Nipro Corporation
  • Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • PCI Pharma Services
  • Pfizer Inc.
  • Reed-Lane, Inc.
  • Ropack Inc.
  • Sepha Limited
  • Sharp Services, LLC
  • Southwest Packaging
  • SternMaid GmbH
  • Unicep Packaging, LLC
  • Wasdell Group
  • West Pharmaceutical Services, Inc.
Product Code: MRR-2A0283E25592

The Pharmaceutical Contract Packaging Market was valued at USD 32.07 billion in 2023, expected to reach USD 34.82 billion in 2024, and is projected to grow at a CAGR of 8.91%, to USD 58.30 billion by 2030.

Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to third-party providers. This industry segment is essential because it allows pharmaceutical companies to focus on their core competencies, such as drug development and marketing, while leveraging the specialized expertise and capabilities of contract packagers in ensuring compliance with industry standards and regulations. The necessity of contract packaging stems from the increasing complexity of drug formulations and packaging requirements, heightened regulatory scrutiny, and the push towards more sustainable packaging solutions. Applications of contract packaging include blister packaging, bottle filling, labeling, and secondary packaging, with end-use scope spanning from contract manufacturing organizations (CMOs) to pharma companies producing over-the-counter (OTC) medications and prescription drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 32.07 billion
Estimated Year [2024] USD 34.82 billion
Forecast Year [2030] USD 58.30 billion
CAGR (%) 8.91%

Market insights indicate that key growth factors include heightened demand for biologics and specialty drugs necessitating innovative packaging solutions, increased outsourcing trends in the pharma industry, and advancements in packaging technologies like serialization and track-and-trace systems. Opportunities for market players include expanding service portfolios to encompass eco-friendly packaging solutions and adopting digital technologies to streamline packaging processes. Moreover, geographic expansion into emerging markets with growing pharmaceutical industries presents a lucrative prospect. However, challenges include stringent regulatory requirements, cost pressures, and demand fluctuations due to global economic uncertainties.

Innovation prospects lie in developing smart packaging solutions that enhance patient adherence, improve supply chain transparency, and facilitate authentication. Continued research into biodegradable and recyclable materials can offer a competitive edge. The nature of the market is highly competitive and dynamic, driven by rapid technological advancements and regulatory changes. For sustainable business growth, companies should invest in state-of-the-art technologies and foster strategic partnerships or alliances to enhance their service offerings. Additionally, a proactive approach to compliance and a strong focus on customer-specific needs will be critical in navigating the challenges and seizing opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Contract Packaging Market

The Pharmaceutical Contract Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for convenient and tamper-free packaging in pharmaceutical industries
    • Rise manufacturing and export of pharmaceutical products worldwide
    • Stringent government standards for pharmaceutical packaging
  • Market Restraints
    • High cost of advanced and customized pharmaceutical contract packaging services
  • Market Opportunities
    • Technological advancements in pharmaceutical packaging solutions
    • Significant investments in drug discovery and development
  • Market Challenges
    • Newly developed drugs conflicting with packaging material and advertising forged products

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Contract Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Contract Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Contract Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Contract Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Contract Packaging Market

A detailed market share analysis in the Pharmaceutical Contract Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Contract Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Contract Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Contract Packaging Market

A strategic analysis of the Pharmaceutical Contract Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Contract Packaging Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Almac Group, AmeriPac, Inc., Aphena Pharma Solutions Inc., Assemblies Unlimited Inc., Baxter Pharmaceutical Solutions LLC, Catalent, Inc., Central Pharma Contract Packing Limited, Daito Pharmaceutical Co., Ltd., Daklapack Group, Finishing Services, Jam Jams Group, Jones Healthcare Group, MJS Packaging, Nelipak Corporation, Nipro Corporation, Patheon Pharma Services by Thermo Fisher Scientific Inc., PCI Pharma Services, Pfizer Inc., Reed-Lane, Inc., Ropack Inc., Sepha Limited, Sharp Services, LLC, Southwest Packaging, SternMaid GmbH, Unicep Packaging, LLC, Wasdell Group, and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Contract Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material, market is studied across Aluminum Foil, Glass, Paper & Paperboard, and Plastics & Polymers.
  • Based on Application, market is studied across Ampoules, Blister Packs, Bottles, and Vials.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for convenient and tamper-free packaging in pharmaceutical industries
      • 5.1.1.2. Rise manufacturing and export of pharmaceutical products worldwide
      • 5.1.1.3. Stringent government standards for pharmaceutical packaging
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced and customized pharmaceutical contract packaging services
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in pharmaceutical packaging solutions
      • 5.1.3.2. Significant investments in drug discovery and development
    • 5.1.4. Challenges
      • 5.1.4.1. Newly developed drugs conflicting with packaging material and advertising forged products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Contract Packaging Market, by Material

  • 6.1. Introduction
  • 6.2. Aluminum Foil
  • 6.3. Glass
  • 6.4. Paper & Paperboard
  • 6.5. Plastics & Polymers

7. Pharmaceutical Contract Packaging Market, by Application

  • 7.1. Introduction
  • 7.2. Ampoules
  • 7.3. Blister Packs
  • 7.4. Bottles
  • 7.5. Vials

8. Americas Pharmaceutical Contract Packaging Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Contract Packaging Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Contract Packaging Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Almac Group
  • 3. AmeriPac, Inc.
  • 4. Aphena Pharma Solutions Inc.
  • 5. Assemblies Unlimited Inc.
  • 6. Baxter Pharmaceutical Solutions LLC
  • 7. Catalent, Inc.
  • 8. Central Pharma Contract Packing Limited
  • 9. Daito Pharmaceutical Co., Ltd.
  • 10. Daklapack Group
  • 11. Finishing Services
  • 12. Jam Jams Group
  • 13. Jones Healthcare Group
  • 14. MJS Packaging
  • 15. Nelipak Corporation
  • 16. Nipro Corporation
  • 17. Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • 18. PCI Pharma Services
  • 19. Pfizer Inc.
  • 20. Reed-Lane, Inc.
  • 21. Ropack Inc.
  • 22. Sepha Limited
  • 23. Sharp Services, LLC
  • 24. Southwest Packaging
  • 25. SternMaid GmbH
  • 26. Unicep Packaging, LLC
  • 27. Wasdell Group
  • 28. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL CONTRACT PACKAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL CONTRACT PACKAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ALUMINUM FOIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PAPER & PAPERBOARD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTICS & POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2023